Estebanez-Perpina E, Arnold LA, Nguyen P, Rodrigues ED, Mar E, Bateman R, et al
Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA
Eric Topol, in a July 2025 review of the evidence on peptide therapies, grouped ipamorelin with CJC-1295 and tesamorelin as growth-hormone-related peptides that "carry the potential risk of cancer" on mechanistic grounds, because sustained IGF-1 elevation promotes cell proliferation broadly [4]
Who Should Use Caution: Those with highly reactive skin or on prescription topical treatments should consult a dermatologist beforehand
January 2025: Ozempics warning label was updated to include severe pancreatitis and kidney injuries